Nocardia strain

Chemistry: molecular biology and microbiology – Micro-organism – per se ; compositions thereof; proces of... – Bacteria or actinomycetales; media therefor

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 120

Patent

active

043761666

ABSTRACT:
New antibiotically active compounds having the basic structure of rifamycin S, namely 3-hydroxyrifamycin S (formula A: X=<C.dbd.O; R.sup.1 =OH; R.sup.2 =H), 3,31-dihydroxyrifamycin S (formula A: X=<C.dbd.O; R.sup.1 =R.sup.2 =OH) and 1-desoxy-1-oxarifamycin S (formula A: X=--O--; R.sup.1 =R.sup.2 =H) ##STR1## are formed by cultivating, under aerobic conditions, a strain of Nocardia mediterranei which is derived from Streptomyces mediterranei ATCC 13 685 as the parent strain and is characterized by the ability to produce at least one of the mentioned compounds. The recombinant strain Nocardia mediterranei DSM 1415 has proved suitable. The mentioned rifamycin S analogues have analogous antibiotic properties to this but have a wider range of action, especially against gram-negative bacteria.

REFERENCES:
Schupp et al. J. Bacteriology vol. 121 No. 1 pp. 128-136.
Helvetia Chimica Acta vol. 56, Fasc. 7 (1973) No. 239-240-2279.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Nocardia strain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nocardia strain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nocardia strain will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1734594

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.